COVID-19
BD’s rapid COVID-19 test granted Emergency Use Authorization by FDA
April 1, 2021BD, COVID-19, COVID-19 testing, EUA, FDA
The FDA has granted Emergency Use Authorization (EUA) for Becton, Dickinson and Company’s (BD) rapid antigen test to be used …
Pharmafile.com’s weekly COVID-19 news round-up
March 31, 2021Research and Development COVID-19, covid 19 news, covid-19 news, covid-19 roundup
The past week has seen plenty of positive COVID-19 news; Starpharma are to start selling their COVID-fighting nose spray in …
Celonic to manufacture at least 100 million CureVac COVID-19 jabs
March 31, 2021Research and Development COVID-19, COVID-19 vaccine, CureVac, colonic, vaccine production
Celonic are to manufacture more than 100 million doses of CureVac’s COVID-19 vaccine, with 50 million shots expected to be …
J & J to ship up to 400 million vaccines to Africa
March 30, 2021Manufacturing and Production COVAX, COVID-19, COVID-19 vaccine, Janssen, Johnson & Johnson
Johnson & Johnson has reached an agreement to ship as many as 400 million doses of their COVID-19 vaccine to …
GSK to support manufacture of 60m Novavax COVID-19 vaccines
March 30, 2021Manufacturing and Production COVID-19, GSK, UK, Vaccine
GSK has reached an agreement with Novavax and the UK Government Vaccines Taskforce to support the production of up to …
500,000 Moderna COVID-19 vaccines to arrive in UK next month
March 29, 2021Sales and Marketing COVID-19, Moderna, Vaccine
More than 500,000 doses of Moderna’s COVID-19 vaccine are set to arrive in the UK next month, ministers have confirmed. …
GSK & Vir’s COVID-19 treatment shows 85% efficacy in Phase III trial
March 29, 2021Sales and Marketing COVID-19, GSK, Phase III trial, covid-19 treatment, vir
GSK and Vir Biotechnology have submitted an Emergency Use Authorization request to the FDA for their VIR-7831 therapy for the …
Pharmafile.com’s top 10 news stories of the week
March 26, 2021Medical Communications AstraZeneca vaccine, COVID-19, covid 19 news, covid-19 news, news, news roundup, starpharma
In the last week, a number of new developments have made the news; for COVID-19, Starpharma will begin to sell …
Novavax delays 100 million vaccines to the EU
March 26, 2021Medical Communications COVID-19, EU, Vaccine
Novavax is delaying the signing of a contract to supply COVID-19 vaccines to the EU, as the company warned it …
Pfizer begins COVID-19 vaccine testing on young children
March 26, 2021Medical Communications COVID-19, Pfizer, Vaccine
Pfizer have begun testing its COVID-19 vaccine on children under the age of 12, with the trials’ first participants, a …
Starpharma to sell COVID-fighting nose spray in UK
March 25, 2021COVID-19
Australian biotech company, Starpharma, has announced a deal with LloydsPharmacy to sell its COVID-fighting antiviral nasal spray, Viraleze, in the …
Merck and UCLA find new COVID-19 treatment candidate
March 25, 2021COVID-19, Merck, berzosertib, covid-19 treatment, ucla
Merck (MSD in the UK), the UCLA, and other universities from the US and Germany have uncovered a compound that …
AstraZeneca vaccine found to be 3% less effective after further trial analysis
March 25, 2021AstraZeneca, AstraZeneca vaccine, COVID-19, COVID-19 vaccine, Vaccine
AstraZeneca have revised their findings from the US study AZD1222 of their COVID-19 vaccine, announcing a 76% efficacy against symptoms …
NHS agrees on MSD interim colorectal cancer treatment
March 25, 2021COVID-19, Cancer, MSD, NHS
MSD has announced a provisional agreement with the NHS to make KEYTRUDA (pembrolizumab) available for eligible patients with metastatic MSI-H/dMMR …
AstraZeneca and J&J COVID-19 vaccines face viral vector shortage
March 25, 2021Astrazenaca, COVID-19, Johnson & Johnson, Vaccine
Both AstraZeneca and J&J face major manufacturing deficiencies for their recombinant vector COVID-19 vaccines, forcing competition over limited production capacity …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
